Pfizer fight with Starboard heats up, hedge fund alleges executive pressure
The corporate clash between Pfizer and Starboard Value heated up on Thursday when the activist investment firm pressed the U.S. drugmaker to investigate actions by its board, after two former executives backed out of its campaign against the company.
Pfizer’s situation with activist investor Starboard Value is already getting messy. | After initially supporting a meeting ...
(Reuters) -Former Pfizer CEO Ian Read and ex-CFO Frank D'Amelio said they will not be involved with activist investor ...
On today's episode of Market Domination Overtime, hosts Julie Hyman and Josh Lipton delve into the top stories following ...
Activist investor Starboard Value has taken a stake of about $1 billion in Pfizer and wants the U.S. drug giant to make ...
September CPI rose 0.2%; Weekly jobless claims at 258k. Domino's Pizza misses slightly on revenue, sets cautious guidance; ...
Activist investor Starboard Value has taken a roughly $1 billion stake in Pfizer and wants the U.S. drug giant to make ...
As activist Starboard teams up with former Pfizer executives, the pharma giant’s lack of focus is in the spotlight.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback